2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

The 2025 Diabetes Clinical Practice Guidelines, developed by the Korean Diabetes Association (KDA), aim to provide evidence-based recommendations for the diagnosis, screening, prevention, and treatment of diabetes and its complications (Supplementary Table 1).The target population for these guidelines includes people with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), children and adolescents with T2DM, gestational diabetes, and adults with prediabetes.The guidelines have been restructured and updated from the '2023 Diabetes Management Guideline' to serve as a comprehensive resource for a wide range of healthcare professionals involved in diabetes care, including general physicians, specialists, private practitioners, diabetes care physicians in educational institutions, nurses, nutritionists, exercise therapists, social workers, policy makers, and other professionals.By promoting evidence-based treatments, providing alternatives to risky or unnecessary interventions, and incorporating essential information on crucial aspects of diabetes care, these guidelines strive to enhance the overall quality of diabetes care in Korea, improve health outcomes, and reduce healthcare costs.Ultimately, the guidelines aim to empower healthcare professionals to make informed decisions and deliver the best possible care to people with diabetes, thereby improving their quality of life and reducing mortality rates. DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS1. Diagnose diabetes based on glycosylated hemoglobin (HbA1c) or plasma glucose criteria, either the fasting plasma glucose (FPG) level, 2-hour plasma glucose (2-h PG) level during a 75 g oral glucose tolerance test (OGTT), or random plasma glucose level accompanied by classic hyperglycemic symptoms [Nonrandomized controlled trial, general recommendation] Recommendation 1.1.Diagnose diabetes based on HbA1c or plasma glucose criteria, either the FPG level, 2-h PG level during a 75 g OGTT, or random plasma glucose level accompanied by classic hyperglycemic symptoms.[Non-randomized controlled trial, general recommendation] Key question Is testing HbA1c, FPG, 2-h PG during a 75 g OGTT, and random plasma glucose in the presence of hyperglycemic symptoms appropriate for diagnosing diabetes and predicting complications?

Authors

Institutions

Publication Details

Journal
Diabetes & Metabolism Journal
Published
2025-07-01
DOI
https://doi.org/10.4093/dmj.2025.0469
Citations
15
Primary Topic
Clinical practice guidelines implementation
Type
article
Field-Weighted Citation Impact
28.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

Joonho Moon, Byung‐Wan Lee, Yong Hee Hong, Ju-Young Moon et al.
15 citations
Diabetes & Metabolism Journal
Clinical practice guidelines implementation
28.18
article

2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

Joonho Moon, Byung‐Wan Lee, Yong Hee Hong, Ju-Young Moon, Bong Soo, Bo Kyung Koo, Min Kyong Moon, You‐Bin Lee, Suk Chon, Shinae Kang, Kee‐Ho Song, Ji Yoon Ahn, Woo Je Lee, Seon Mee Kang, You‐Cheol Hwang, Soo‐Kyung Kim, Eon Ju Jeon, Jae Won Cho, YoonJu Song, Eugene Han, Jong Han Choi, Jeong Hyun Lim, Hyuk-Sang Kwon, Se Hee Min, Ji Yun Noh, Jae Hyun Bae, Chong Hwa Kim, Jaehyun Bae, Sun Joon Moon, Sang‐Man Jin, Jieun Lee, Jae Hyeon Kim, Sung Eun Kim, Young‐Eun Kim, Jung Hwan Park, Ji Yeon Choi, Hae Jin Kim, Eun Sook Kim, Mi Kyung Kim, Sang Yong Kim, Ji Min Kim, Seung-Hyun Ko, Jae-Seung Yun
article en
15 citations

Abstract

The 2025 Diabetes Clinical Practice Guidelines, developed by the Korean Diabetes Association (KDA), aim to provide evidence-based recommendations for the diagnosis, screening, prevention, and treatment of diabetes and its complications (Supplementary Table 1).The target population for these guidelines includes people with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), children and adolescents with T2DM, gestational diabetes, and adults with prediabetes.The guidelines have been restructured and updated from the '2023 Diabetes Management Guideline' to serve as a comprehensive resource for a wide range of healthcare professionals involved in diabetes care, including general physicians, specialists, private practitioners, diabetes care physicians in educational institutions, nurses, nutritionists, exercise therapists, social workers, policy makers, and other professionals.By promoting evidence-based treatments, providing alternatives to risky or unnecessary interventions, and incorporating essential information on crucial aspects of diabetes care, these guidelines strive to enhance the overall quality of diabetes care in Korea, improve health outcomes, and reduce healthcare costs.Ultimately, the guidelines aim to empower healthcare professionals to make informed decisions and deliver the best possible care to people with diabetes, thereby improving their quality of life and reducing mortality rates. DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS1. Diagnose diabetes based on glycosylated hemoglobin (HbA1c) or plasma glucose criteria, either the fasting plasma glucose (FPG) level, 2-hour plasma glucose (2-h PG) level during a 75 g oral glucose tolerance test (OGTT), or random plasma glucose level accompanied by classic hyperglycemic symptoms [Nonrandomized controlled trial, general recommendation] Recommendation 1.1.Diagnose diabetes based on HbA1c or plasma glucose criteria, either the FPG level, 2-h PG level during a 75 g OGTT, or random plasma glucose level accompanied by classic hyperglycemic symptoms.[Non-randomized controlled trial, general recommendation] Key question Is testing HbA1c, FPG, 2-h PG during a 75 g OGTT, and random plasma glucose in the presence of hyperglycemic symptoms appropriate for diagnosing diabetes and predicting complications?

Diabetes & Metabolism JournalVol. 49(4)
Ulsan College (KR), Seoul National University (KR), Chosun University (KR), Yonsei University (KR), Chungnam National University (KR), Korea University (KR), Soonchunhyang University (KR), Seoul Metropolitan Government (KR), Asan Medical Center (KR), Samsung Medical Center (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), Daegu Catholic University (KR), University of Ulsan (KR), Konkuk University Medical Center (KR), The Catholic University of Korea St. Vincent's Hospital (KR), Hallym University Kangnam Sacred Heart Hospital (KR), SNUH SMG-SNU Boramae Medical Center (KR), The Catholic University of Korea Incheon St. Mary's Hospital (KR), Kangbuk Samsung Hospital (KR), Inje University Ilsan Paik Hospital (KR), The Catholic University of Korea Yeouido St. Mary's Hospital (KR), Kyung Hee University Medical Center (KR), Keimyung University Dongsan Medical Center (KR), Sejong General Hospital (KR), CHA University Bundang Medical Center (KR), CHA University (KR), Kyung Hee University Hospital at Gangdong (KR), Yeungnam University College, Hanyang University (KR), Keimyung University (KR), Yeungnam University (KR), Ajou University (KR), Bucheon University (KR), Sungkyunkwan University (KR), Catholic University of Korea (KR)
Korean Diabetes Association
Openalex Percentile: Top 0%
Clinical practice guidelines implementation
28.18
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.